Disclosure
Affiliate and Referral Disclosure
Tirzepatide Editorial earns no affiliate commission, referral fee, or sponsorship revenue from any provider or pharmacy named on this site. Outbound links carry rel="nofollow noopener" and a UTM parameter used only for first-party traffic analytics. No link on this site is monetised, and none carries a rel="sponsored" attribute because nothing is sponsored.
Key takeaways
- No affiliate commission, referral fee, or sponsorship revenue is earned from any company covered.
- Outbound provider links are rel="nofollow noopener" and are not marked sponsored, because they are not.
- UTM parameters on outbound links are first-party analytics only and pay nobody.
- No provider can pay for inclusion, ranking position, or wording.
- One provider, NexLife, currently receives a persistent on-site placement. It is unpaid editorial placement, disclosed here and labelled within the placement itself.
- Any future paid arrangement would be labelled at the point of use before it began.
| Affiliate commission | None |
|---|---|
| Referral fees | None |
| Sponsored content | None |
| Link attributes | rel="nofollow noopener" — not "sponsored", because no link is sponsored |
| UTM parameters | First-party analytics only; no revenue attached |
| Paid placement | Not offered |
What is the NexLife placement, and why does it exist?
A persistent site-wide element currently promotes NexLife. It is important to describe it accurately rather than leave a reader to infer what it is. No payment, affiliate commission, referral fee, or sponsorship is involved, and NexLife has no ownership or commercial relationship with this publication. It is an editorial placement chosen by the publisher.
It is not neutral, and this page does not claim otherwise. A persistent placement gives one provider prominence that the other twenty-three do not receive, and a reader is entitled to weigh that when reading anything on this site about NexLife. The placement states the provider's verified price and its ranked position, and it does not claim NexLife is the cheapest option, because it is not.
The placement does not affect ranking eligibility, ordering, or exclusions. Rankings are computed from the shared eligibility function described in the methodology, and NexLife is subject to the same test as every other provider. At the current dataset snapshot that test places NexLife second on verified cost, and the ranking pages say so.
| Question | Answer |
|---|---|
| Is any payment involved? | No |
| Affiliate or referral commission? | No |
| Does it affect ranking position? | No — rankings are computed from published data |
| Does it claim NexLife is cheapest? | No — NexLife ranks second on verified cost |
| Can it be dismissed? | Yes, it can be closed on any page |
| Is it labelled? | Yes, within the placement itself |
If nothing is monetised, why do links carry UTM parameters?
So that this publication can see which of its own pages send traffic outward, which is ordinary first-party analytics. A UTM parameter is a label written by this site for this site's own reporting. It carries no commission, no partner identifier, and no payment mechanism, and the destination gains nothing from it.
Why not use rel="sponsored" on provider links?
Because rel="sponsored" is the correct attribute for links that are paid for, and none of these are. Marking an unpaid link as sponsored would be inaccurate in the opposite direction — it would imply a commercial relationship that does not exist. Unpaid outbound commercial links take rel="nofollow".
How much of this site's data is actually verified?
| Group | Records |
|---|---|
| Trials with full identifiers | 8 |
| Trials partially verified | 1 |
| Trials withheld pending audit | 1 |
| Providers with verified all-in price | 5 |
| Providers excluded with reason | 19 |
| Evidence status | Definition | What may be published |
|---|---|---|
| Verified | Checked against a primary source with a recorded date | The claim, with its identifier and date |
| Partially verified | Some elements confirmed, others outstanding | Confirmed elements only; the rest labelled |
| Verification Pending | Not yet checked against a primary source | No factual assertion — the gap is shown |
What does this page cover, and what does it deliberately leave out?
This page addresses Paid and unpaid links, sponsored attributes and ranking safeguards, organised around the primary question of tirzepatide affiliate disclosure. Each of those elements is treated separately below rather than blended, because they carry different evidence weights and a reader is entitled to know which parts rest on randomised data and which rest on a captured commercial claim or a regulatory document.
| Element | Treatment here | Evidence basis |
|---|---|---|
| Paid and unpaid links | Covered on this page | Regulatory or policy source |
| Sponsored attributes | Covered on this page | Regulatory or policy source |
| Ranking safeguards | Covered on this page | Regulatory or policy source |
| Individualized clinical instruction | Deliberately not covered | Belongs with the corrections process |
What are the limits of what this page can tell you?
Every page on this site rests on a specific published policy, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.
- The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for the corrections process.
- Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
- Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
- Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.
What would change the conclusion on this page?
The following would trigger a revision to this page, recorded in its change history:
- New primary evidence bearing directly on tirzepatide affiliate disclosure.
- A change to FDA labelling affecting any statement made above.
- A verified correction submitted through the corrections process and accepted on the evidence.
- A material change to a captured record, including a price, term, or regulatory status.
- Completion of a verification currently marked pending, which would replace a gap with a stated fact.
Frequently asked questions
Do you earn commission when I click a provider link?
No. No link on this site is monetised.
Why do the links have tracking parameters?
They are first-party analytics labels so this site can see its own outbound traffic. They pay nobody.
Why are links not marked sponsored?
Because nothing is sponsored, and marking an unpaid link as sponsored would be inaccurate.
Can a provider pay to be ranked higher?
No. Paid placement is not offered.
Change history
| Date | Change |
|---|---|
| 2026-07-22 | Page published with current dataset snapshot. |
Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.